Recombinant SARS-CoV-2 NSP8 (C-6His)

Recombinant SARS-CoV-2 NSP8 (C-6His)

Size1:10μg price1:$136
Size2:50μg price2:$378
Size3:500μg price3:$2190
SKU: PEV2236 Category: Target Proteins Tags: ,

Datasheet

Name

Recombinant SARS-CoV-2 NSP8 (C-6His)

Purity

Greater than 95% as determined by reducing SDS-PAGE

Endotoxin level

Please contact with the lab for this information

Construction

Recombinant 2019-nCoV NSP8 is produced by our E.coli expression system and the target gene encoding Ala1-Gln198 is expressed with a 6His tag at the C-terminus.

Accession #

YP_009725304.1

Host

E.coli

Species

SARS-CoV-2

Predicted Molecular Mass

25 KDa

Buffer

Supplied as a 0.2 μm filtered solution of 20mM Tris-HCl, 150mM NaCl, 10% Glycerol, pH 8.5.

Form

Liquid

Shipping

The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below.

Stability&Storage

Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

 

 

 

Alternative Names

SARS-CoV 2 nsp8

 

Background

Cleavage by the viral main protease, 3CLpro results in generating the nsp8 protein, The nsp8 protein has been shown to associate with several other nsps and to colocalize with these nsps in cytoplasmic complexes that are important for viral RNA synthesis. It forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers.Nsp8 was shown to have RNA-dependent RNA polymerase (RdRp) activity that could be involved in producing primers utilized by nsp12 which is normally accepted to be the RdRp for SARS-CoV.

 

Note

For Research Use Only , Not for Diagnostic Use.